[Impact of complicated myocardial injury on the clinical outcome of severe or critically ill COVID-19 patients].
Identifieur interne : 000509 ( PubMed/Curation ); précédent : 000508; suivant : 000510[Impact of complicated myocardial injury on the clinical outcome of severe or critically ill COVID-19 patients].
Auteurs : X W He [République populaire de Chine] ; J S Lai [République populaire de Chine] ; J. Cheng [République populaire de Chine] ; M W Wang [République populaire de Chine] ; Y J Liu [République populaire de Chine] ; Z C Xiao [République populaire de Chine] ; C. Xu [République populaire de Chine] ; S S Li [République populaire de Chine] ; H S Zeng [République populaire de Chine]Source :
- Zhonghua xin xue guan bing za zhi [ 0253-3758 ] ; 2020.
Abstract
Objective: To analyze the clinical characteristics of the severe or critically ill patients with novel coronavirus pneumonia (COVID-19), and evaluate the impact of complicated myocardial injury on the prognosis of these patients. Methods: A retrospective study was conducted in 54 patients who admitted to Tongji hospital from February 3, 2020 to February 24, 2020 and met the criteria of severe or critical conditions of COVID-19. The clinical characteristics and hospital mortality rate were analyzed and compared between the patients with or without myocardial injury, which was defined with 3 times higher serum cardiac troponin value. Results: The median age of the 54 patients was 68 (59.8, 74.3) years. Among all the patients, 24 (44.4%) patients were complicated with hypertension, 13 (24.1%) with diabetes, 8 (14.8%) with coronary heart disease, and 3 (5.6%) with previous cerebral infarction. During hospitalization, 24 (44.4%) of the patients were complicated with myocardial injury and 26 (48.1%) patients died in hospital. In-hospital mortality was significantly higher in patients with myocardial injury than in patients without myocardial injury (14 (60.9%) vs. 8 (25.8%), P=0.013). Moreover, the levels of C-reactive protein (153.6 (80.3, 240.7) ng/L vs. 49.8 (15.9, 101.9) ng/L) and N-terminal pro-B-type natriuretic peptide (852.0 (400.0, 2 315.3) ng/L vs. 197.0 (115.3, 631.0) ng/L) were significantly higher than patients without myocardial injury (all P<0.01). Conclusions: Prevalence of myocardial injury is high among severe or critically ill COVID-19 patients. Severe or critically ill COVID-19 patients with myocardial injury face a significantly higher risk of in-hospital mortality. The study suggests that it is important to monitor and manage the myocardial injury during hospitalization for severe or critically ill COVID-19 patients.
DOI: 10.3760/cma.j.cn112148-20200228-00137
PubMed: 32171190
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000509
Links to Exploration step
pubmed:32171190Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Impact of complicated myocardial injury on the clinical outcome of severe or critically ill COVID-19 patients].</title><author><name sortKey="He, X W" sort="He, X W" uniqKey="He X" first="X W" last="He">X W He</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Cardiology, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030</wicri:regionArea></affiliation></author><author><name sortKey="Lai, J S" sort="Lai, J S" uniqKey="Lai J" first="J S" last="Lai">J S Lai</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Cardiology, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030</wicri:regionArea></affiliation></author><author><name sortKey="Cheng, J" sort="Cheng, J" uniqKey="Cheng J" first="J" last="Cheng">J. Cheng</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Cardiology, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030</wicri:regionArea></affiliation></author><author><name sortKey="Wang, M W" sort="Wang, M W" uniqKey="Wang M" first="M W" last="Wang">M W Wang</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Cardiology, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030</wicri:regionArea></affiliation></author><author><name sortKey="Liu, Y J" sort="Liu, Y J" uniqKey="Liu Y" first="Y J" last="Liu">Y J Liu</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Cardiology, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030</wicri:regionArea></affiliation></author><author><name sortKey="Xiao, Z C" sort="Xiao, Z C" uniqKey="Xiao Z" first="Z C" last="Xiao">Z C Xiao</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Cardiology, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030</wicri:regionArea></affiliation></author><author><name sortKey="Xu, C" sort="Xu, C" uniqKey="Xu C" first="C" last="Xu">C. Xu</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Cardiology, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030</wicri:regionArea></affiliation></author><author><name sortKey="Li, S S" sort="Li, S S" uniqKey="Li S" first="S S" last="Li">S S Li</name><affiliation wicri:level="1"><nlm:affiliation>Department of Emergency, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Emergency, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030</wicri:regionArea></affiliation></author><author><name sortKey="Zeng, H S" sort="Zeng, H S" uniqKey="Zeng H" first="H S" last="Zeng">H S Zeng</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Cardiology, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030</wicri:regionArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32171190</idno><idno type="pmid">32171190</idno><idno type="doi">10.3760/cma.j.cn112148-20200228-00137</idno><idno type="wicri:Area/PubMed/Corpus">000509</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000509</idno><idno type="wicri:Area/PubMed/Curation">000509</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000509</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[Impact of complicated myocardial injury on the clinical outcome of severe or critically ill COVID-19 patients].</title><author><name sortKey="He, X W" sort="He, X W" uniqKey="He X" first="X W" last="He">X W He</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Cardiology, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030</wicri:regionArea></affiliation></author><author><name sortKey="Lai, J S" sort="Lai, J S" uniqKey="Lai J" first="J S" last="Lai">J S Lai</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Cardiology, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030</wicri:regionArea></affiliation></author><author><name sortKey="Cheng, J" sort="Cheng, J" uniqKey="Cheng J" first="J" last="Cheng">J. Cheng</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Cardiology, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030</wicri:regionArea></affiliation></author><author><name sortKey="Wang, M W" sort="Wang, M W" uniqKey="Wang M" first="M W" last="Wang">M W Wang</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Cardiology, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030</wicri:regionArea></affiliation></author><author><name sortKey="Liu, Y J" sort="Liu, Y J" uniqKey="Liu Y" first="Y J" last="Liu">Y J Liu</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Cardiology, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030</wicri:regionArea></affiliation></author><author><name sortKey="Xiao, Z C" sort="Xiao, Z C" uniqKey="Xiao Z" first="Z C" last="Xiao">Z C Xiao</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Cardiology, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030</wicri:regionArea></affiliation></author><author><name sortKey="Xu, C" sort="Xu, C" uniqKey="Xu C" first="C" last="Xu">C. Xu</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Cardiology, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030</wicri:regionArea></affiliation></author><author><name sortKey="Li, S S" sort="Li, S S" uniqKey="Li S" first="S S" last="Li">S S Li</name><affiliation wicri:level="1"><nlm:affiliation>Department of Emergency, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Emergency, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030</wicri:regionArea></affiliation></author><author><name sortKey="Zeng, H S" sort="Zeng, H S" uniqKey="Zeng H" first="H S" last="Zeng">H S Zeng</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Cardiology, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030</wicri:regionArea></affiliation></author></analytic><series><title level="j">Zhonghua xin xue guan bing za zhi</title><idno type="ISSN">0253-3758</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><b>Objective:</b> To analyze the clinical characteristics of the severe or critically ill patients with novel coronavirus pneumonia (COVID-19), and evaluate the impact of complicated myocardial injury on the prognosis of these patients. <b>Methods:</b> A retrospective study was conducted in 54 patients who admitted to Tongji hospital from February 3, 2020 to February 24, 2020 and met the criteria of severe or critical conditions of COVID-19. The clinical characteristics and hospital mortality rate were analyzed and compared between the patients with or without myocardial injury, which was defined with 3 times higher serum cardiac troponin value. <b>Results:</b> The median age of the 54 patients was 68 (59.8, 74.3) years. Among all the patients, 24 (44.4%) patients were complicated with hypertension, 13 (24.1%) with diabetes, 8 (14.8%) with coronary heart disease, and 3 (5.6%) with previous cerebral infarction. During hospitalization, 24 (44.4%) of the patients were complicated with myocardial injury and 26 (48.1%) patients died in hospital. In-hospital mortality was significantly higher in patients with myocardial injury than in patients without myocardial injury (14 (60.9%) vs. 8 (25.8%), <i>P</i>=0.013). Moreover, the levels of C-reactive protein (153.6 (80.3, 240.7) ng/L vs. 49.8 (15.9, 101.9) ng/L) and N-terminal pro-B-type natriuretic peptide (852.0 (400.0, 2 315.3) ng/L vs. 197.0 (115.3, 631.0) ng/L) were significantly higher than patients without myocardial injury (all <i>P</i><0.01). <b>Conclusions:</b> Prevalence of myocardial injury is high among severe or critically ill COVID-19 patients. Severe or critically ill COVID-19 patients with myocardial injury face a significantly higher risk of in-hospital mortality. The study suggests that it is important to monitor and manage the myocardial injury during hospitalization for severe or critically ill COVID-19 patients.</div></front></TEI><pubmed><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">32171190</PMID><DateRevised><Year>2020</Year><Month>03</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0253-3758</ISSN><JournalIssue CitedMedium="Print"><Volume>48</Volume><Issue>0</Issue><PubDate><Year>2020</Year><Month>Mar</Month><Day>15</Day></PubDate></JournalIssue><Title>Zhonghua xin xue guan bing za zhi</Title><ISOAbbreviation>Zhonghua Xin Xue Guan Bing Za Zhi</ISOAbbreviation></Journal><ArticleTitle>[Impact of complicated myocardial injury on the clinical outcome of severe or critically ill COVID-19 patients].</ArticleTitle><Pagination><MedlinePgn>E011</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3760/cma.j.cn112148-20200228-00137</ELocationID><Abstract><AbstractText><b>Objective:</b> To analyze the clinical characteristics of the severe or critically ill patients with novel coronavirus pneumonia (COVID-19), and evaluate the impact of complicated myocardial injury on the prognosis of these patients. <b>Methods:</b> A retrospective study was conducted in 54 patients who admitted to Tongji hospital from February 3, 2020 to February 24, 2020 and met the criteria of severe or critical conditions of COVID-19. The clinical characteristics and hospital mortality rate were analyzed and compared between the patients with or without myocardial injury, which was defined with 3 times higher serum cardiac troponin value. <b>Results:</b> The median age of the 54 patients was 68 (59.8, 74.3) years. Among all the patients, 24 (44.4%) patients were complicated with hypertension, 13 (24.1%) with diabetes, 8 (14.8%) with coronary heart disease, and 3 (5.6%) with previous cerebral infarction. During hospitalization, 24 (44.4%) of the patients were complicated with myocardial injury and 26 (48.1%) patients died in hospital. In-hospital mortality was significantly higher in patients with myocardial injury than in patients without myocardial injury (14 (60.9%) vs. 8 (25.8%), <i>P</i>=0.013). Moreover, the levels of C-reactive protein (153.6 (80.3, 240.7) ng/L vs. 49.8 (15.9, 101.9) ng/L) and N-terminal pro-B-type natriuretic peptide (852.0 (400.0, 2 315.3) ng/L vs. 197.0 (115.3, 631.0) ng/L) were significantly higher than patients without myocardial injury (all <i>P</i><0.01). <b>Conclusions:</b> Prevalence of myocardial injury is high among severe or critically ill COVID-19 patients. Severe or critically ill COVID-19 patients with myocardial injury face a significantly higher risk of in-hospital mortality. The study suggests that it is important to monitor and manage the myocardial injury during hospitalization for severe or critically ill COVID-19 patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>He</LastName><ForeName>X W</ForeName><Initials>XW</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lai</LastName><ForeName>J S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>M W</ForeName><Initials>MW</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Y J</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiao</LastName><ForeName>Z C</ForeName><Initials>ZC</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>S S</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Department of Emergency, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeng</LastName><ForeName>H S</ForeName><Initials>HS</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>chi</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>03</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Zhonghua Xin Xue Guan Bing Za Zhi</MedlineTA><NlmUniqueID>7910682</NlmUniqueID><ISSNLinking>0253-3758</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><OtherAbstract Type="Publisher" Language="chi"><AbstractText><b>目的：</b> 分析重型/危重型新型冠状病毒肺炎（COVID-19）的临床特征，评估合并心肌损伤对患者预后的影响。 <b>方法：</b> 回顾性分析2020年2月3日至2020年2月24日于华中科技大学同济医学院附属同济医院中法新城院区收治的54例重型/危重型COVID-19确诊病例，年龄68.0（59.8，74.3）岁，男34例（63.0%），分析其临床特征。并根据是否合并心肌损伤（高敏心肌肌钙蛋白>正常上限3倍以上，并排除急性心肌梗死、心功能不全失代偿、慢性肾功能衰竭）将患者分为合并心肌损伤组和未合并心肌损伤组，比较两组患者临床特征的差异。 <b>结果：</b> 所有患者中合并高血压24例（44.4%），糖尿病13例（24.1%），冠心病8例（14.8%），既往脑梗死3例（5.6%）。住院期间合并心肌损伤24例（44.4%），院内死亡26例（48.1%）。按有无心肌损伤将患者分为合并心肌损伤组（24例）和未合并心肌损伤组（30例）。两组在年龄、性别、合并症等方面差异均无明显统计学意义（<i>P</i>均<0.05）。但心肌损伤组患者，院内死亡率明显高于未合并心肌损伤组[75.0%（18/24）比26.7%（8/30），<i>P</i>=0.001]。同时心肌损伤组的C反应蛋白[153.6（80.3, 240.7）ng/L比49.8（15.9, 101.9）ng/L]和氨基末端B型利钠肽原[852.0（400.0, 2 315.3）ng/L比197.0（115.3, 631.0）ng/L]水平也明显高于未合并心肌损伤组（<i>P</i>均<0.01）。 <b>结论：</b> 重型/危重型COVID-19多为老年患者，合并症多，发生心肌损伤的比例高。合并心肌损伤的患者具有更高的院内死亡率。因此，应加强住院期间心肌损伤标记物和心功能的监测，重视合并心肌损伤的治疗。.</AbstractText></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Myocardial injury</Keyword><Keyword MajorTopicYN="N">Troponin</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>3</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>3</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>3</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32171190</ArticleId><ArticleId IdType="doi">10.3760/cma.j.cn112148-20200228-00137</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000509 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000509 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= CovidV2
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:32171190
|texte= [Impact of complicated myocardial injury on the clinical outcome of severe or critically ill COVID-19 patients].
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:32171190" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a CovidV2
| This area was generated with Dilib version V0.6.33. |  |